Scholarly publications and presentations by Rochester Regional Health's Infectious Diseases department authors.

Follow


Submissions from 2017

Link

12-12-2017          An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults, Judith Falloon, MedImmune, Gaithersburg, Maryland., Jing Yu, MedImmune, Gaithersburg, Maryland., Mark T. Esser, MedImmune, Gaithersburg, Maryland., et al.

Link

12-7-2017          Importation, Mitigation, and Genomic Epidemiology of Candida auris at a Large Teaching Hospital, Emil P. Lesho, Rochester Regional Health, Melissa Z. Bronstein, Rochester Regional Health, Patrick McGann, Multidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, Maryland., et al.

Link

11-15-2017          Viral Diagnostics: Only Half the Battle, Angela R. Branche, Department of Medicine, University of Rochester. and Ann R. Falsey, Rochester Regional Health

Link

8-29-2017          Pseudomona s Endocarditis with an unstable phenotype: the challenges of isolate characterization and Carbapenem stewardship with a partial review of the literature, Emil Lesho, Rochester Regional Health, Erik Snesrud, Multidrug-resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, MD USA., Yoon Kwak, Multidrug-resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, MD USA., et al.

Link

7-26-2017          Transcriptomic Biomarkers to Discriminate Bacterial from Nonbacterial Infection in Adults Hospitalized with Respiratory Illness, Soumyaroop Bhattacharya, Division of Neonatology and Pediatric Molecular and Personalized Medicine Program, Department of Pediatrics, University of Rochester School Medicine, Rochester, NY, USA., Alex F. Rosenberg, Division of Allergy Immunology & Rheumatology, Department of Medicine, University of Rochester School Medicine, Rochester, NY, USA., Derick R. Peterson, Department of Biostatistics and Computational Biology, University of Rochester School Medicine, Rochester, NY, USA., et al.

Link

4-1-2017          Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons, Ann R. Falsey, Rochester Regional Health, Christine Koval, Cleveland Clinic, Cleveland, OH, USA., John P. DeVincenzo, Department of Pediatrics and Microbiology, Immunology and Biochemistry, University of Tennessee Center for Health Sciences, Children's Foundation Research Institute at LeBonheur Children's Hospital, Memphis, TN, USA., et al.

Submissions from 2016

Link

1-1-2016          Treatment with novel RSV Ig RI-002 controls viral replication and reduces pulmonary damage in immunocompromised Sigmodon hispidus, M Boukhvalova, Department of Molecular Biology/Virology, Sigmovir Biosystems, Inc., Rockville, MD, USA., J C. Blanco, Department of Molecular Biology/Virology, Sigmovir Biosystems, Inc., Rockville, MD, USA., Ann R. Falsey, Rochester Regional Health, et al.

Submissions from 2015

Link

10-16-2015          Activation of persons living with HIV for treatment, the great study Health behavior, health promotion and society, Kevin Fiscella, University of Rochester Medical Center, Michele Boyd, University of Rochester Medical Center, Julian Brown, Trillium Health, et al.